Your browser doesn't support javascript.
loading
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta, Meenu; Satija, Saurabh; Paudel, Keshav R; Malyla, Vamshikrishna; Kannaujiya, Vinod Kumar; Chellappan, Dinesh Kumar; Bebawy, Mary; Hansbro, Philip M; Wich, Peter R; Dua, Kamal.
Afiliação
  • Mehta M; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.
  • Satija S; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
  • Paudel KR; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia.
  • Malyla V; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.
  • Kannaujiya VK; School of Chemical Engineering, University of New South Wales, Sydney, NSW, Australia.
  • Chellappan DK; Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.
  • Bebawy M; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia.
  • Hansbro PM; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia.
  • Wich PR; School of Chemical Engineering, University of New South Wales, Sydney, NSW, Australia; Centre for Nanomedicine, University of New South Wales, Sydney, NSW, Australia.
  • Dua K; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia; Priority Research Centre for Healthy Lungs, University of Newcastle & Hunter Medical Research Institute, New Lambton Heights,
Nanomedicine ; 31: 102303, 2021 01.
Article em En | MEDLINE | ID: mdl-32980549

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Nanopartículas / Antagomirs Limite: Animals / Humans Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Nanopartículas / Antagomirs Limite: Animals / Humans Idioma: En Revista: Nanomedicine Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália